(Source: Tilray Medical Germany)
Tilray Medical, a division of Tilray Brands, is adding new cannabis extract products to its German medical portfolio. A report by Prohibition Partners estimated that German medical cannabis sales would exceed €420 million in 2024 and surpass €1 billion by 2028. The tailwind has prompted other notable names to enter the space, such as High Tide and MediPharm Labs.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Decibel Cannabis strengthens vape dominance
2 | PharmaTher updates FDA new drug application for Ketamine
3 | Planet 13 partners with Future, Mike Tyson, and Ric Flair
4 | Canopy Growth expands Deep Space Propulsion lineup with two new flavours
Top Cannabis Stocks Feb.. 7 to Feb. 14, 2025
1. T.TLRY | 5,449 views | Tilray Brands Inc.
2. C.CURA | 4,481 views | Curaleaf Holdings Inc.
3.T.WEED | 4,047 views | Canopy Growth Corp.
4. T.LABS | 1,766 views | Medipharm Labs Corp.
5. C.OILS | 846 views | Nextleaf Solutions Inc.
6. C.TGIF | 635views | 1933 Industries Inc.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.